LRRK2 variation and dementia with Lewy bodies.

[1]  T. Montine,et al.  Cognitive profile of LRRK2‐related Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[2]  Chuong B. Do,et al.  Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease , 2014, Nature Genetics.

[3]  W. M. van der Flier,et al.  Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies , 2014, Human molecular genetics.

[4]  M. Murray,et al.  Differential clinicopathologic and genetic features of late-onset amnestic dementias , 2014, Acta Neuropathologica.

[5]  M. Nalls,et al.  A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. , 2013, JAMA neurology.

[6]  Daniel Weintraub,et al.  APOE ε4 increases risk for dementia in pure synucleinopathies. , 2013, JAMA neurology.

[7]  P. Deyn,et al.  DLB and PDD: a role for mutations in dementia and Parkinson disease genes? , 2012, Neurobiology of Aging.

[8]  J. Ioannidis,et al.  Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study , 2011, The Lancet Neurology.

[9]  J. Jankovic,et al.  Multiple LRRK2 variants modulate risk of Parkinson disease: a chinese multicenter study , 2010, Human mutation.

[10]  A. González-Neira,et al.  Early-Onset Familial Lewy Body Dementia With Extensive Tauopathy: A Clinical, Genetic, and Neuropathological Study , 2009, Journal of neuropathology and experimental neurology.

[11]  M. Toft,et al.  CORTICOBASAL SYNDROME AND PRIMARY PROGRESSIVE APHASIA AS MANIFESTATIONS OF LRRK2 GENE MUTATIONS , 2008, Neurology.

[12]  J. Molinuevo,et al.  Screening for the LRRK2 G2019S and codon-1441 mutations in a pathological series of parkinsonian syndromes and frontotemporal lobar degeneration , 2008, Journal of the Neurological Sciences.

[13]  R. Petersen,et al.  Validation of the Neuropathologic Criteria of the Third Consortium for Dementia With Lewy Bodies for Prospectively Diagnosed Cases , 2008, Journal of neuropathology and experimental neurology.

[14]  M. Farrer,et al.  Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease , 2008, Annals of neurology.

[15]  J. Trojanowski,et al.  Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations , 2008, Neurology.

[16]  T. Meitinger,et al.  A novel LRRK2 mutation in an Austrian cohort of patients with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[17]  M. Farrer,et al.  Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions , 2007, Acta Neuropathologica.

[18]  M. Farrer,et al.  Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. , 2007, Parkinsonism & related disorders.

[19]  J. Cappell,et al.  Tiagabine-induced nonconvulsive status epilepticus in an adolescent without epilepsy , 2006, Neurology.

[20]  Irene Litvan,et al.  Lrrk2 and Lewy body disease , 2006, Annals of neurology.

[21]  S Minoshima,et al.  Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.

[22]  Thomas Meitinger,et al.  Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.

[23]  D W Dickson,et al.  Autosomal dominant parkinsonism associated with variable synuclein and tau pathology , 2004, Neurology.

[24]  H. Payami,et al.  Genetic Epidemiology of Parkinson's Disease , 1998, Journal of geriatric psychiatry and neurology.

[25]  R. Katzman.,et al.  Senile Dementia of the Alzheimer Type Without Neocortical Neurofibrillary Tangles , 1987, Journal of neuropathology and experimental neurology.

[26]  K Kosaka,et al.  Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease? , 1984, Clinical neuropathology.

[27]  O. Ross,et al.  Genetic susceptibility variants in parkinsonism. , 2016, Parkinsonism & Related Disorders.

[28]  J. Trojanowski,et al.  Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. , 2015, JAMA neurology.

[29]  G. Halliday,et al.  α-Synucleinopathy phenotypes. , 2014, Parkinsonism & related disorders.

[30]  A. Brice,et al.  Role of mendelian genes in "sporadic" Parkinson's disease. , 2012, Parkinsonism & related disorders.

[31]  N. Kumar.  Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations , 2009 .

[32]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.